SAH

CAS No. 979-92-0

SAH( SAH (S-Adenosylhomocysteine) )

Catalog No. M21671 CAS No. 979-92-0

SAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 34 In Stock
10MG 46 In Stock
25MG 82 In Stock
50MG 147 In Stock
100MG 219 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SAH
  • Note
    Research use only, not for human use.
  • Brief Description
    SAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).
  • Description
    SAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SAH (S-Adenosylhomocysteine)
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    979-92-0
  • Formula Weight
    384.41
  • Molecular Formula
    C14H17N6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 125 mg/mL (325.17 mM; Need ultrasonic)
  • SMILES
    N[C@@H](CCSC[C@@H]1[C@]([C@]([C@](N2C=NC3=C2N=CN=C3N)O1)O)O)C(O)=O
  • Chemical Name
    (5S)-2-amino-5-((2S3S4R5R)-5-(6-amino-9H-purin-9-yl)-34-dihydroxytetrahydrofuran-2-yl)-5-mercaptopentanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.DE LA HABA G et al. The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. J Biol Chem. 1959 Mar;234(3):603-8.
molnova catalog
related products
  • LysoFos Choline 12

    LysoFos Choline 12 (1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine) is an amphoteric surfactant that acts as a biofilm mimic for self-aggregation in aqueous solution.

  • Lindcarpine

    Lindcarpine

  • 20-Hydroxylucidenic ...

    20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.